Pasithea Therapeutics Corp. (KTTA) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Miami Beach, FL, 미국. 현재 CEO는 Tiago Reis Marques.
KTTA 을(를) 보유 IPO 날짜 2021-09-15, 4 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $5.37M.
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
